ITMI960352A0 - - Google Patents

Info

Publication number
ITMI960352A0
ITMI960352A0 ITMI960352A ITMI960352A ITMI960352A0 IT MI960352 A0 ITMI960352 A0 IT MI960352A0 IT MI960352 A ITMI960352 A IT MI960352A IT MI960352 A ITMI960352 A IT MI960352A IT MI960352 A0 ITMI960352 A0 IT MI960352A0
Authority
IT
Italy
Application number
ITMI960352A
Other languages
Italian (it)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11373387&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ITMI960352(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed filed Critical
Priority to IT96MI000352A priority Critical patent/IT1282686B1/it
Publication of ITMI960352A0 publication Critical patent/ITMI960352A0/it
Priority to PT97906115T priority patent/PT904110E/pt
Priority to RU98117618/14A priority patent/RU2192247C2/ru
Priority to EP02008079A priority patent/EP1221326A3/en
Priority to EP97906115A priority patent/EP0904110B1/en
Priority to KR1019980706501A priority patent/KR19990087113A/ko
Priority to DK97906115T priority patent/DK0904110T3/da
Priority to DE69714253T priority patent/DE69714253T2/de
Priority to SI9730286T priority patent/SI0904110T1/xx
Priority to JP9530576A priority patent/JP2000506133A/ja
Priority to PCT/EP1997/000873 priority patent/WO1997031654A1/en
Priority to CA002247848A priority patent/CA2247848C/en
Priority to BR9707739A priority patent/BR9707739A/pt
Priority to ES97906115T priority patent/ES2180938T3/es
Priority to AT97906115T priority patent/ATE220920T1/de
Priority to AU20924/97A priority patent/AU706591B2/en
Priority to HU9900993A priority patent/HUP9900993A3/hu
Publication of ITMI960352A1 publication Critical patent/ITMI960352A1/it
Publication of IT1282686B1 publication Critical patent/IT1282686B1/it
Application granted granted Critical
Priority to US10/885,121 priority patent/US7087588B2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Toxicology (AREA)
  • Pulmonology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Underground Structures, Protecting, Testing And Restoring Foundations (AREA)
IT96MI000352A 1996-02-26 1996-02-26 Composti in grado di ridurre la tossicita' da farmaci IT1282686B1 (it)

Priority Applications (18)

Application Number Priority Date Filing Date Title
IT96MI000352A IT1282686B1 (it) 1996-02-26 1996-02-26 Composti in grado di ridurre la tossicita' da farmaci
HU9900993A HUP9900993A3 (en) 1996-02-26 1997-02-24 Nitric oxide donors capable of reducing toxicity from drugs
JP9530576A JP2000506133A (ja) 1996-02-26 1997-02-24 薬剤由来の毒性を減少させることができる酸化窒素供与体
PCT/EP1997/000873 WO1997031654A1 (en) 1996-02-26 1997-02-24 Nitric oxide donors capable of reducing toxicity from drugs
EP02008079A EP1221326A3 (en) 1996-02-26 1997-02-24 Nitric oxide donors capable of reducing toxicity from drugs
EP97906115A EP0904110B1 (en) 1996-02-26 1997-02-24 Nitric oxide donors capable of reducing toxicity from drugs
KR1019980706501A KR19990087113A (ko) 1996-02-26 1997-02-24 약품으로 인한 독성을 경감할 수 있는 산화질소 도너
DK97906115T DK0904110T3 (da) 1996-02-26 1997-02-24 Nitrogenoxid-afgivende sammensætninger til nedsættelse af lægemidlers toksicitet
DE69714253T DE69714253T2 (de) 1996-02-26 1997-02-24 Stickstoffoxydabgebendes präparat zur reduzierung der toxizität von wirkstoffen
SI9730286T SI0904110T1 (en) 1996-02-26 1997-02-24 Nitric oxide donors capable of reducing toxicity from drugs
PT97906115T PT904110E (pt) 1996-02-26 1997-02-24 Dadores de oxido nitrico capazes de reduzir a toxicidade causada por farmacos
RU98117618/14A RU2192247C2 (ru) 1996-02-26 1997-02-24 Доноры окиси азота, способные снижать токсичность от лекарственных препаратов
CA002247848A CA2247848C (en) 1996-02-26 1997-02-24 Nitric oxide donors capable of reducing toxicity from drugs
BR9707739A BR9707739A (pt) 1996-02-26 1997-02-24 Utilizacão de compostos orgânicos
ES97906115T ES2180938T3 (es) 1996-02-26 1997-02-24 Donadores de oxido nitrico capaces de reducir la toxicidad de los farmacos.
AT97906115T ATE220920T1 (de) 1996-02-26 1997-02-24 Stickstoffoxydabgebendes präparat zur reduzierung der toxizität von wirkstoffen
AU20924/97A AU706591B2 (en) 1996-02-26 1997-02-24 Nitric oxide donors capable of reducing toxicity from drugs
US10/885,121 US7087588B2 (en) 1996-02-26 2004-07-07 Nitric oxide donors capable of reducing toxicity from drugs

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT96MI000352A IT1282686B1 (it) 1996-02-26 1996-02-26 Composti in grado di ridurre la tossicita' da farmaci

Publications (3)

Publication Number Publication Date
ITMI960352A0 true ITMI960352A0 (en:Method) 1996-02-26
ITMI960352A1 ITMI960352A1 (it) 1997-08-26
IT1282686B1 IT1282686B1 (it) 1998-03-31

Family

ID=11373387

Family Applications (1)

Application Number Title Priority Date Filing Date
IT96MI000352A IT1282686B1 (it) 1996-02-26 1996-02-26 Composti in grado di ridurre la tossicita' da farmaci

Country Status (16)

Country Link
US (1) US7087588B2 (en:Method)
EP (2) EP1221326A3 (en:Method)
JP (1) JP2000506133A (en:Method)
KR (1) KR19990087113A (en:Method)
AT (1) ATE220920T1 (en:Method)
AU (1) AU706591B2 (en:Method)
BR (1) BR9707739A (en:Method)
CA (1) CA2247848C (en:Method)
DE (1) DE69714253T2 (en:Method)
DK (1) DK0904110T3 (en:Method)
ES (1) ES2180938T3 (en:Method)
HU (1) HUP9900993A3 (en:Method)
IT (1) IT1282686B1 (en:Method)
PT (1) PT904110E (en:Method)
RU (1) RU2192247C2 (en:Method)
WO (1) WO1997031654A1 (en:Method)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6043232A (en) * 1997-07-23 2000-03-28 Nitromed, Inc. Nitroso esters of beta-oxo-amides and aryl propionic acid derivatives of non-steroidal antiinflammatory drugs
US5703073A (en) * 1995-04-19 1997-12-30 Nitromed, Inc. Compositions and methods to prevent toxicity induced by nonsteroidal antiinflammatory drugs
GB9801398D0 (en) 1998-01-22 1998-03-18 Anggard Erik E Chemical compounds
IT1298338B1 (it) * 1998-03-05 1999-12-20 Nicox Sa Composizioni farmaceutiche per l'ulcera
JP2002528495A (ja) 1998-10-30 2002-09-03 ニトロメド インコーポレーテッド ニトロソ化およびニトロシル化された非ステロイド抗炎症性化合物、組成物および使用方法
TWI243672B (en) * 1999-06-01 2005-11-21 Astrazeneca Ab New use of compounds as antibacterial agents
TWI262791B (en) 1999-10-27 2006-10-01 Nobex Corp 6-methoxy-2-naphthylacetic acid prodrugs
US6436990B1 (en) 1999-10-27 2002-08-20 Nobex Corporation 6-methoxy-2-naphthylacetic acid prodrugs
US6552078B2 (en) 1999-10-27 2003-04-22 Nobex Corp 6-methoxy-2-naphthylacetic acid prodrugs
AP2002002582A0 (en) 1999-12-23 2002-09-30 Nitromed Inc Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use
US7018979B1 (en) 2000-01-26 2006-03-28 Cedars-Sinai Medical Center Method for using potassium channel agonists for delivering a medicant to an abnormal brain region and/or a malignant tumor
AU2001233052A1 (en) * 2000-01-26 2001-08-07 Cedars-Sinai Medical Center Method for using potassium channel activation for delivering a medicant to an abnormal brain region and/or a malignant tumor
CA2432642A1 (en) 2000-12-21 2002-08-08 Subhash P. Khanapure Substituted aryl compounds as novel cyclooxygenase-2 selective inhibitors, compositions and methods of use
EP1219306A1 (en) * 2000-12-29 2002-07-03 Nicox S.A. Compositions comprising cyclodextrins and NO- releasing drugs
US7211561B2 (en) 2001-10-12 2007-05-01 Cedars-Sinai Medical Center Method for inducing selective cell death of malignant cells by activation of calcium-activated potassium channels (KCa)
US7378438B2 (en) 2002-04-19 2008-05-27 Yissum Research Development Company Of The Hebrew University Of Jerusalem Beta-agonist compounds comprising nitric oxide donor groups and reactive oxygen species scavenger groups and their use in the treatment of respiratory disorders
EP1539134A4 (en) 2002-06-11 2007-04-11 Nitromed Inc SELECTIVE INHIBITORS OF CYCLOOXIGENASE-2 NITROSIS AND / OR NITROSYLES, COMPOSITIONS AND METHODS OF USE
JP2005535642A (ja) 2002-06-28 2005-11-24 ニトロメッド インコーポレーティッド オキシムおよび／またはヒドラゾンを含有するニトロソ化および／またはニトロシル化シクロオキシゲナーゼ−２選択的阻害剤、組成物、および使用方法
JP2005539089A (ja) 2002-07-03 2005-12-22 ニトロメッド インコーポレーティッド ニトロソ化非ステロイド性抗炎症化合物、組成物および使用方法
AU2003261281A1 (en) 2002-07-29 2004-02-16 Nicox S.A. Cyclooxygenase- 2 selective inhibitors, compositions and methods of use
SE0300971D0 (sv) * 2003-04-03 2003-04-03 Aga Ab Nitric oxide in treatment of inflammation
AU2005206227A1 (en) * 2004-01-27 2005-08-04 Merck Frosst Company Combination therapy for treating cyclooxygenase-2 mediated diseases or conditions in patients at risk of thrombotic cardiovascular events
EP1778215B1 (en) * 2004-06-10 2009-12-09 Nippon Kayaku Kabushiki Kaisha Anticancer effect enhancer
JP2007325501A (ja) * 2004-08-25 2007-12-20 Tottori Univ 非ステロイド性抗炎症薬による動物の消化管副作用の予防・治療方法
EP1888510A4 (en) 2005-05-27 2013-01-16 Univ North Carolina NITROGEN OXIDE-RELATED PARTICLES FOR NITROGEN OXIDE THERAPEUTICS AND BIOMEDICAL APPLICATIONS
US20100240745A1 (en) * 2009-03-20 2010-09-23 Nicox S.A. Method of treatment of inflammation in hypertensive patients
EP2467173B8 (en) 2009-08-21 2019-06-19 Novan, Inc. Wound dressings, methods of using the same and methods of forming the same
EP4249001A3 (en) 2009-08-21 2023-11-29 Novan, Inc. Topical gels
US8591876B2 (en) 2010-12-15 2013-11-26 Novan, Inc. Methods of decreasing sebum production in the skin
ES2695173T3 (es) 2011-02-28 2019-01-02 Novan Inc Partículas de sílice modificadas con S-nitrosotiol que liberan óxido nítrico y procedimientos de fabricación de las mismas
JO3350B1 (ar) 2011-03-07 2019-03-13 Merck Sharp & Dohme مشتقات حلقية غير متجانسة محتوية على مجموعات أمينو أولية ومركبات داي أزينيومديولات
RU2539630C1 (ru) * 2013-07-09 2015-01-20 Федеральное государственное автономное образовательное учреждение высшего профессионального образования "Белгородский государственный национальный исследовательский университет" (НИУ "БелГУ") Способ профилактики ишемии сетчатки в эксперименте

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5570683A (en) 1990-12-05 1996-11-05 The General Hospital Corporation Methods and devices for treating pulmonary vasoconstriction and asthma
IT1256345B (it) 1992-08-20 1995-12-01 Esteri nitrici di derivati dell'acido 2-(2,6-di-alo-fenilammino) fenilacetico e procedimento per la loro preparazione
IT1256450B (it) 1992-11-26 1995-12-05 Soldato Piero Del Esteri nitrici con attivita' farmacologica e procedimento per la loro preparazione
CA2173582C (en) 1993-10-06 2006-11-28 Piero Del Soldato Nitric esters having anti-inflammatory and/or analgesic activity and process for their preparation
HU227280B1 (en) 1994-05-10 2011-01-28 Nicox Sa Nitro compounds and their compositions having anti-inflammatory, analgesic and antithrombotic acitivities
US5597809A (en) * 1994-06-23 1997-01-28 Massachusetts Eye & Ear Infirmary Treatment of optic neuritis
US5703073A (en) 1995-04-19 1997-12-30 Nitromed, Inc. Compositions and methods to prevent toxicity induced by nonsteroidal antiinflammatory drugs
US5620416A (en) 1995-06-07 1997-04-15 North Carolina State University Methods of using topical agents with systemically administered active agents

Also Published As

Publication number Publication date
ES2180938T3 (es) 2003-02-16
RU2192247C2 (ru) 2002-11-10
US7087588B2 (en) 2006-08-08
CA2247848C (en) 2008-07-15
AU2092497A (en) 1997-09-16
DE69714253D1 (de) 2002-08-29
DE69714253T2 (de) 2003-03-06
HUP9900993A2 (hu) 1999-09-28
IT1282686B1 (it) 1998-03-31
US20040242651A1 (en) 2004-12-02
ATE220920T1 (de) 2002-08-15
EP0904110B1 (en) 2002-07-24
EP0904110A1 (en) 1999-03-31
EP1221326A2 (en) 2002-07-10
WO1997031654A1 (en) 1997-09-04
JP2000506133A (ja) 2000-05-23
EP1221326A3 (en) 2004-01-14
CA2247848A1 (en) 1997-09-04
AU706591B2 (en) 1999-06-17
KR19990087113A (ko) 1999-12-15
DK0904110T3 (da) 2002-11-11
BR9707739A (pt) 1999-07-27
ITMI960352A1 (it) 1997-08-26
PT904110E (pt) 2002-12-31
HUP9900993A3 (en) 2000-10-30

Similar Documents

Publication Publication Date Title
FR11C0018I1 (en:Method)
AR026660A2 (en:Method)
IN189909B (en:Method)
IN192922B (en:Method)
ITMI960352A0 (en:Method)
IN190710B (en:Method)
FR05C0032I1 (en:Method)
IN191524B (en:Method)
IN191473B (en:Method)
ITAR960006A0 (en:Method)
IN183239B (en:Method)
IN186637B (en:Method)
ITMI960591A0 (en:Method)
IN181800B (en:Method)
ITGE960014A0 (en:Method)
ITMC960037V0 (en:Method)
ITMC960050A0 (en:Method)
ITMI960214A0 (en:Method)
IN184659B (en:Method)
ITMI960481V0 (en:Method)
IN188206B (en:Method)
IN186893B (en:Method)
IN185275B (en:Method)
CN3045911S (en:Method)
CN3044348S (en:Method)

Legal Events

Date Code Title Description
0001 Granted